tiprankstipranks
Trending News
More News >
Everest Medicines Ltd. (HK:1952)
:1952
Hong Kong Market
Advertisement

Everest Medicines Ltd. (1952) Similar Stocks

Compare
3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Everest Medicines Ltd.
HK$57.80
HK$20.43B
144.40%
0 Buy
2 Hold
0 Sell
Hold
InnoCare Pharma Ltd.
HK$16.44
HK$24.57B
200.55%
2 Buy
1 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$7.65
HK$14.22B
153.31%
0 Buy
0 Hold
0 Sell
Hold
Keymed Biosciences, Inc.
HK$72.10
HK$20.24B
104.83%
1 Buy
0 Hold
0 Sell
Moderate Buy
CARsgen Therapeutics Holdings Ltd.
HK$21.06
HK$12.13B
609.09%
0 Buy
0 Hold
1 Sell
Moderate Sell
Shanghai Haohai Biological Technology Co., Ltd. Class H
HK$26.64
HK$12.24B
14.48
-8.20%
0 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1952
Everest Medicines Ltd.
57.80
34.15
144.40%
HK:9969
InnoCare Pharma Ltd.
16.44
10.97
200.55%
HK:2157
Lepu Biopharma Co. Ltd. Class H
7.65
4.63
153.31%
HK:2162
Keymed Biosciences, Inc.
72.10
36.90
104.83%
HK:2171
CARsgen Therapeutics Holdings Ltd.
21.06
18.09
609.09%
HK:6826
Shanghai Haohai Biological Technology Co., Ltd. Class H
26.64
-2.38
-8.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis